eli lilly retatrutide clinical trials Retatrutide, Lilly's next generation of weight loss injections, showed dramatic results in trials, with patients losing an average of up to 71.2 pounds, or 28.7% of their body weight. Eli Lilly's 'triple G' agonist triumphs

Retatrutide is an investigational triple agonist of GIP, GLP-1, and glucagon receptors developed by Eli Lilly

Many people who think retatrutide ruined their exercise capacity are actually just dehydrated

The good news is that many users of branded GLP-1s qualify for partial or full insurance coverage, especially if they have diabetes or a BMI over 30

It can help with mild to moderate laxity by supporting collagen rebuilding and tightening, and it can be used on both face and select body areas

Mounjaro (tirzepatide) EPAR Product Information EMA

These expertly crafted hydro facial serums contain a powerful blend of natural extracts and active ingredients to enhance skin texture, hydration, and overall health